Added 21 days ago Drug news

Study of PCI patients with Impella 2.5 heart pump published in Journal of Interventional Cardiology- Abiomed

Abiomed announced the publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5 heart pump. The study...

Added 1 month ago Congress news

Excess risk of cardiovascular events in Rheumatoid Arthritis patients decreased since start of 21st Century

Recent improvements in RA management may be driving positive change

Added 4 months ago Drug news

FDA grants premarket approval for Hospital Wearable Defibrillator from Zoll Medical/Asahi Kasei.

ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced that the company’s...

European Guidelines for the management of acute coronary syndromes in patients presenting wihout persistent ST-segment elevation

The present document deals with the management of patients with suspected NSTE-ACS, replacing the document first published in 2000 and...

Added 1 year ago

ESC/EACTS Guidelines on Myocardial Revascularisation

In 2014, coronary artery bypass grafting (CABG) celebrates the 50th anniversary of the first procedures performed in 1964. Thirteen years...

Added 2 years ago

MI – secondary prevention: Secondary prevention in primary and secondary care for patients following a myocardial infarction

Myocardial infarction (MI) is one of the most dramatic presentations of coronary artery disease. It is usually caused by blockage...

Added 3 years ago

Cangrelor: A New Route for P2Y12 Inhibition.

Antiplatelet therapy with a P2Y12 inhibitor is a key component of treatment for patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Added 2 months ago

The Association Between Testosterone Use and Major Adverse Cardiovascular Events (MACE): An Exploratory Retrospective Cohort Analysis of Two Large, Contemporary, Coronary Heart Disease Clinical Trials

The cardiovascular (CV) safety profile of testosterone replacement therapy (TRT) in men is uncertain, particularly in older individuals with pre-existing coronary heart disease (CHD)

Added 2 months ago

Risk of myocardial infarction in older men receiving testosterone therapy.

Testosterone therapy for older men has increased substantially over the past decade. Research on the effects of testosterone therapy on cardiovascular outcomes has yielded inconsistent results.

Added 4 months ago